- Ray Flynn received artificial retinal degeneration dry age-related macular
- The 80-year-old is the first person to treatment that will help thousands could
- Surgeons implanted chips on the back of the eye in step 4 hours in the last month
- Retired factory supervisor can now make shapes with their eyes closed
120
View
Comments
Ray Flynn, 80, (pictured) from Audenshaw, Manchester, the first patient in the world to receive an artificial retinal degeneration associated with dry macular Ages
A revolutionary bionic eye implant has restored the sight of a British man.
Ray Flynn, 80, from Audenshaw, Manchester, the first patient in the world to an artificial retina for dry macular degeneration with age (AMD) is assigned to get the most common cause of vision problems in the UK was.
Hundreds of thousands of people who could the misery of the technology that has been used only for those with a rare eye disease benefit.
Surgeons at Manchester Royal Eye Hospital implanted a chip in the back of the eye Flynn on a four-hour procedure in the past month.
The supervisor of the system can now retired make shapes with their eyes closed - proof that the system works.
Since AMD was eight years ago with the vision of Mr Flynn diagnosed gradually deteriorated until he see clearly in the corner of his eye.
Now the £ 80,000 procedure has restored their central vision, allowing you to read a newspaper without a magnifying glass for the first time in years.
Surgeons now the Argus II retinal implant more patients place in the coming months to prove it will work for a variety of patients. They hope that eventually the system will be available on the NHS.
Macular degeneration affects 500,000 people in the UK, 85 percent of them with the dry form of the disease. It occurs when cells damaged in the center of the retina, leading to loss of central vision.
The bionic system works by transmitting video images from a camera for special glasses, into electrical impulses that are read by the brain captured.
Electronic signals are transmitted through a network of electrodes attached to the damaged cells in the back of the retina.
The impulses stimulate the remaining cells of the retina, whereby corresponding patterns of the light perception in the brain.
Patients learn to interpret these visual patterns in order to recover some of the visual function.
Professor Paulo stagnation (right) of the Fund for the Wellcome Trust Clinical Research at the Hospital of the University of Manchester, Checks (left) eye Flynn
Excreted The plant supervisor (left with Professor Paulo stagnation and right) can now make shapes with their eyes closed - proof that the system works,
Mr. Flynn said that makes it easy while you get used to the system, but. Already in your daily life
He said: "Before, when I looked at a plant in the garden, which go like a honeycomb in the center of the eye, which is gone now I can now through the garden and see what was ..."
Turned on your system for the first time on July 1, and the evidence showed that he could do the outlines of people and objects, even with your eyes closed.
Professor Paulo Stanga, ophthalmologist consultant at Manchester Royal Eye Hospital, said: "Mr Flynn progression is truly remarkable, he sees the outlines of people and objects very well ..
"Ray, had everything to do with his peripheral vision - is very tiring, it's exhausting.
"This new information the brain of Ray and his brain has to get used to interpret them now."
£ 80,000 procedure restored their central vision, allowing you to read a newspaper without a magnifying glass for the first time in years
Mr. Flynn said that makes it easy while you get used to the system, but already in your daily life
The Argus II retinal implant has been used in 130 patients with retinitis pigmentosa, a rare eye disease. However, the patient, in contrast to Mr. Flynn, had no peripheral vision.
The new system is believed to be the first in the world to natural and artificial vision, electronic images in the eye center to combine forces with natural images of survivors peripheral retinal cells.
Professor Stanga said he expected that the developed by the US company Second Sight Medical Products system could be used for patients with other vision problems.
But he said, scientists have not yet worked out how to use it for patients who are blind from birth, as these patients have never learned how to deal with the electrical impulses from the eyes.
No comments:
Post a Comment